219 related articles for article (PubMed ID: 17613660)
1. Muco-adhesive multivesicular liposomes as an effective carrier for transmucosal insulin delivery.
Jain AK; Chalasani KB; Khar RK; Ahmed FJ; Diwan PV
J Drug Target; 2007 Jul; 15(6):417-27. PubMed ID: 17613660
[TBL] [Abstract][Full Text] [Related]
2. Bioadhesive Chitosan-Coated Cationic Nanoliposomes With Improved Insulin Encapsulation and Prolonged Oral Hypoglycemic Effect in Diabetic Mice.
Shalaby TI; El-Refaie WM
J Pharm Sci; 2018 Aug; 107(8):2136-2143. PubMed ID: 29689252
[TBL] [Abstract][Full Text] [Related]
3. Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes.
Takeuchi H; Yamamoto H; Niwa T; Hino T; Kawashima Y
Pharm Res; 1996 Jun; 13(6):896-901. PubMed ID: 8792429
[TBL] [Abstract][Full Text] [Related]
4. [Studies on the insulin-liposomes double-coated by chitosan and chitosan-EDTA conjugates].
Wu ZH; Ping QN; Song YM; Lei XM; Li JY; Cai P
Yao Xue Xue Bao; 2004 Nov; 39(11):933-8. PubMed ID: 15696937
[TBL] [Abstract][Full Text] [Related]
5. In situ mucoadhesive-thermosensitive liposomal gel as a novel vehicle for nasal extended delivery of opiorphin.
Mura P; Mennini N; Nativi C; Richichi B
Eur J Pharm Biopharm; 2018 Jan; 122():54-61. PubMed ID: 29032194
[TBL] [Abstract][Full Text] [Related]
6. Nasal delivery of insulin using bioadhesive chitosan gels.
Varshosaz J; Sadrai H; Heidari A
Drug Deliv; 2006; 13(1):31-8. PubMed ID: 16401591
[TBL] [Abstract][Full Text] [Related]
7. Hypoglycemic efficacy of chitosan-coated insulin liposomes after oral administration in mice.
Wu ZH; Ping QN; Wei Y; Lai JM
Acta Pharmacol Sin; 2004 Jul; 25(7):966-72. PubMed ID: 15210073
[TBL] [Abstract][Full Text] [Related]
8. Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats.
Takeuchi H; Matsui Y; Yamamoto H; Kawashima Y
J Control Release; 2003 Jan; 86(2-3):235-42. PubMed ID: 12526820
[TBL] [Abstract][Full Text] [Related]
9. Effect of a controlled-release drug delivery system made of oleanolic acid formulated into multivesicular liposomes on hepatocellular carcinoma in vitro and in vivo.
Luo Y; Liu Z; Zhang X; Huang J; Yu X; Li J; Xiong D; Sun X; Zhong Z
Int J Nanomedicine; 2016; 11():3111-29. PubMed ID: 27471381
[TBL] [Abstract][Full Text] [Related]
10. Preparation of multivesicular liposomes for the loco-regional delivery of Vancomycin hydrochloride using active loading method: drug release and antimicrobial properties.
Vatankhah M; Dadashzadeh S; Mahboubi A; Haeri A; Jandaghi Alaee K; Mostafavi Naeini SB; Abbasian Z
J Liposome Res; 2024 Mar; 34(1):77-87. PubMed ID: 37287348
[TBL] [Abstract][Full Text] [Related]
11. Characterization of pilocarpine-loaded chitosan/Carbopol nanoparticles.
Kao HJ; Lin HR; Lo YL; Yu SP
J Pharm Pharmacol; 2006 Feb; 58(2):179-86. PubMed ID: 16451745
[TBL] [Abstract][Full Text] [Related]
12. N-trimethyl chitosan-coated multivesicular liposomes for oxymatrine oral delivery.
Cao J; Sun J; Wang X; Li X; Deng Y
Drug Dev Ind Pharm; 2009 Nov; 35(11):1339-47. PubMed ID: 19832634
[TBL] [Abstract][Full Text] [Related]
13. [Effects of the liposomes coated by chitosan and its derivatives on the gastrointestinal transit of insulin].
Wu ZH; Ping QN; Lei XM; Li JY; Cai P
Yao Xue Xue Bao; 2005 Jul; 40(7):618-22. PubMed ID: 16196267
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of the intranasal delivery of insulin via a novel mucoadhesive Carbopol gel.
El-Dakrouri WA; Ibrahim HK; Ghorab MK; Ghorab MM
J Pharm Pharmacol; 2010 Jul; 62(7):866-72. PubMed ID: 20636874
[TBL] [Abstract][Full Text] [Related]
15. Enhanced systemic exposure of fexofenadine via the intranasal administration of chitosan-coated liposome.
Qiang F; Shin HJ; Lee BJ; Han HK
Int J Pharm; 2012 Jul; 430(1-2):161-6. PubMed ID: 22525082
[TBL] [Abstract][Full Text] [Related]
16. [Hypoglycemic effect of polysaccharide-coated insulin liposomes after oral administration in mice].
Wu ZH; Ping QN; Lai JM; Wei Y
Yao Xue Xue Bao; 2003 Feb; 38(2):138-42. PubMed ID: 12778751
[TBL] [Abstract][Full Text] [Related]
17. Nasal delivery of insulin using chitosan microspheres.
Varshosaz J; Sadrai H; Alinagari R
J Microencapsul; 2004 Nov; 21(7):761-74. PubMed ID: 15799226
[TBL] [Abstract][Full Text] [Related]
18. Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin.
Bhumkar DR; Joshi HM; Sastry M; Pokharkar VB
Pharm Res; 2007 Aug; 24(8):1415-26. PubMed ID: 17380266
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of mucoadhesive polymer-coated nanoparticles.
Cui F; Qian F; Yin C
Int J Pharm; 2006 Jun; 316(1-2):154-61. PubMed ID: 16567070
[TBL] [Abstract][Full Text] [Related]
20. Effective insulin delivery using starch nanoparticles as a potential trans-nasal mucoadhesive carrier.
Jain AK; Khar RK; Ahmed FJ; Diwan PV
Eur J Pharm Biopharm; 2008 Jun; 69(2):426-35. PubMed ID: 18295464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
